このエントリーをはてなブックマークに追加
ID 55208
JaLCDOI
FullText URL
71_3_249.pdf 3.32 MB
Author
Washio, Kana Department of Pediatrics, Okayama University Hospital
Muraoka, Michiko Department of Pediatrics, National Hospital Organization Fukuyama Medical Center
Kanamitsu, Kiichiro Department of Pediatrics, Okayama University Hospital
Oda, Megumi Department of Pediatrics, Okayama University Hospital
Shimada, Akira Department of Pediatrics, Okayama University Hospital ORCID Kaken ID researchmap
Abstract
 We diagnosed a female infant with Langerhans cell histiocytosis (LCH) who was refractory to conventional chemotherapy. She showed refractory inflammation that was complicated with hemophagocytic lymphohistiocytosis (HLH) during LCH chemotherapy; therefore, we changed the protocol to HLH2004 (dexamethasone, cyclosporine A and VP16). However, there were no signs of hematological recovery. We therefore performed cord blood transplantation with reduced-intensity conditioning, and she achieved complete remission for over 2 years. As salvage therapy for refractory LCH, hematopoietic stem cell transplantation may be a good therapeutic choice, especially when LCH is complicated with HLH.
Keywords
langerhans cell histiocytosis (LCH)
hemophagocytic lymphohistiocytosis (HLH)
hematopoietic stem cell transplantation (HSCT)
reduced-intensity conditioning (RIC)
refractory
Amo Type
Case Report
Publication Title
Acta Medica Okayama
Published Date
2017-06
Volume
volume71
Issue
issue3
Publisher
Okayama University Medical School
Start Page
249
End Page
254
ISSN
0386-300X
NCID
AA00508441
Content Type
Journal Article
language
English
Copyright Holders
CopyrightⒸ 2017 by Okayama University Medical School
File Version
publisher
Refereed
True
PubMed ID